The Section of Epidemiology and Population Sciences at Baylor College of Medicine invites applications for postdoctoral research in systems epidemiology of cancer.
This is a 3-year flexible program with personalized educational curricula and individually tailored multidisciplinary teams of mentors with ongoing research in a variety of pediatric and adult cancers. The training provides epidemiology and bioinformatics fellows with the specialized skills to incorporate novel high-throughput technologies into large-scale collaborative epidemiology studies and to become successful, cross-trained researchers.
Develops new statistical methods to answer biological questions that arise in the research.Ph.D. epidemiologists or bioinformaticians or M.D.s/DVMs with related experience.This program is not restricted to permanent U.S. residents or citizens. Training grant support includes stipend, fringe benefits and a modest travel and research allowance. Other qualifications include excellent writing skills in English. Prior experience with next generation sequencing data analysis is a plus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Postdoctoral Associate- Immunology, T Cells, GVHD, Bone Marrow Transplantation - Houston, Texas (US) job with Baylor College of Medicine (BCM)The laboratory of Dr. Pavan Reddy in the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine is seeking an enthusiastic Postdoctoral Associate who will work on independent and collaborative projects, and who will contribute to the vibrant and team-oriented laboratory environment. Dr.
Read more »
Late punt return for a touchdown lifts Huntingdon over Maryville CollegeThe Huntingdon College Hawks took on the Maryville College Scots on Saturday afternoon in Montgomery
Read more »
‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
Read more »
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.
Read more »
The next generation of challenges and innovation in medicineAmerican health care is seeing a surge of innovation in areas from maternal care to cancer treatments while also facing new challenges like the medical impact of more extreme climate events. On Tuesday, Oct. 17 at 9:00 a.m.
Read more »
Medicine in diabetes drug Mounjaro helped people lose a quarter of body weightIt is under review to treat obesity in the U.S. A decision is expected later this year.
Read more »